Shock Wave Therapy Trial for Knee Osteoarthritis Shows Potential for Clinical Practice Change
A randomized controlled trial is assessing the efficacy of shockwave therapy combined with exercise for knee osteoarthritis.
Phase III
Musculoskeletal / Osteoarthritis
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
The ongoing trial of shockwave therapy for knee osteoarthritis could significantly alter treatment paradigms if successful. This may lead to a shift in clinical practice and influence the competitive landscape for existing therapies in this therapeutic area.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor trial results for pain reduction and functional improvement metrics, as well as potential shifts in treatment protocols.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.